…inhibitors such as pembrolizumab offer a therapeutic option for head and neck squamous cell carcinoma (HNSCC), yet only a minority of patients benefit. Although PD-L…
HNSCC
This disease is selected. Its supporting articles are shown below.
Articles mentioning HNSCC
42 articles · page 2 of 4…n PBMC.Methods Patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) were randomized to receive a heterologous prime-boost r…
…econdary objectives.Results The study enrolled 12 patients with melanoma (n=9), head and neck squamous cell carcinoma (HNSCC; n=1), rena…
… missing variables. Bradley et al developed a BN on survival in pancreatic ductal adenocarcinoma and evaluated the impact of at least two missing variables on t…
…herapy, such as immune checkpoint inhibitors (ICI), outcomes of head and neck squamous cell carcinoma (HNSCC) remain suboptimal, with ICI response rates at ~17% in t…
…ndard of care (SOC) surgical resection.Methods Nine patients (7 HNSCC, 2 cuSCC) received ASP-1929 PIT, followed by SOC surgical resec…
…Background Head and neck squamous cell carcinoma (HNSCC) accounts for 4-7% of all cancers globally with about 50% 5-year…
…ts with either Head and Neck squamous cell carcinoma (HNSCC) or Soft Tissue Sarcoma (STS). Following CIVO intratumoral microdose injections of PBA-…
…c data from seven cohorts spanning four cancer types (n = 314): melanoma; n=100, NSCLC; n=117, TNBC; n=42, and HNSCC; n=55. Each cancer …
…ples from patients with previously treated recurrent/metastatic HNSCC were collected at screening were used to identify spatial histo…
…EX in patients with select advanced solid tumors. Patients with melanoma, NSCLC, HNSCC, CRC, pancreatic, and cervical cancer who have pr…
…ss B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. Nov 26 2020;6(1):92.Chen SMY, Krinsky AL,…